Role of P-glycoprotein in dolastatin 10 resistance

Deborah L. Toppmeyer, Christopher A. Slapak, James Croop, Donald W. Kufe

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Dolastatin 10, a cytotoxic pentapeptide isolated from the mollusk Dolabella auricularia, exhibits potent antitumor activity. The present studies demonstrated that sublines of murine PC4 and human U-937 leukemia cells expressing a multidrug resistance (MDR) phenotype are cross-resistant to this agent. We also demonstrated that such resistance was reversed by verapamil. While these findings suggested the involvement of the P-glycoprotein (P-gp) in dolastatin 10 resistance, we performed similar studies in a CHO cell line transfected with the human mdr 1 cDNA. Expression of P-gp in the transfected cells was associated with resistance to dolastatin 10 by a verapamil-sensitive mechanism. The demonstration that photoaffinity labeling of P-gp was decreased in the presence of dolastatin 10 further supports the interaction of this cytotoxic peptide with P-gp. Taken together, these findings suggest that resistance to dolastatin 10 is conferred, at least in part, by P-gp and that this cytotoxic peptide is a novel member of the MDR phenotype.

Original languageEnglish (US)
Pages (from-to)609-612
Number of pages4
JournalBiochemical Pharmacology
Volume48
Issue number3
DOIs
StatePublished - Aug 3 1994
Externally publishedYes

Fingerprint

dolastatin 10
P-Glycoprotein
Multiple Drug Resistance
Verapamil
Phenotype
Peptides
CHO Cells
Mollusca
Labeling
Leukemia
Demonstrations
Complementary DNA
Cells
Cell Line

Keywords

  • cytotoxic peptides
  • dolastatin 10
  • multidrug resistance
  • P-glycoprotein
  • peptide transport
  • tubulin binding drug

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of P-glycoprotein in dolastatin 10 resistance. / Toppmeyer, Deborah L.; Slapak, Christopher A.; Croop, James; Kufe, Donald W.

In: Biochemical Pharmacology, Vol. 48, No. 3, 03.08.1994, p. 609-612.

Research output: Contribution to journalArticle

Toppmeyer, Deborah L. ; Slapak, Christopher A. ; Croop, James ; Kufe, Donald W. / Role of P-glycoprotein in dolastatin 10 resistance. In: Biochemical Pharmacology. 1994 ; Vol. 48, No. 3. pp. 609-612.
@article{b80c4c0510c346f5aaa5a21cdb142372,
title = "Role of P-glycoprotein in dolastatin 10 resistance",
abstract = "Dolastatin 10, a cytotoxic pentapeptide isolated from the mollusk Dolabella auricularia, exhibits potent antitumor activity. The present studies demonstrated that sublines of murine PC4 and human U-937 leukemia cells expressing a multidrug resistance (MDR) phenotype are cross-resistant to this agent. We also demonstrated that such resistance was reversed by verapamil. While these findings suggested the involvement of the P-glycoprotein (P-gp) in dolastatin 10 resistance, we performed similar studies in a CHO cell line transfected with the human mdr 1 cDNA. Expression of P-gp in the transfected cells was associated with resistance to dolastatin 10 by a verapamil-sensitive mechanism. The demonstration that photoaffinity labeling of P-gp was decreased in the presence of dolastatin 10 further supports the interaction of this cytotoxic peptide with P-gp. Taken together, these findings suggest that resistance to dolastatin 10 is conferred, at least in part, by P-gp and that this cytotoxic peptide is a novel member of the MDR phenotype.",
keywords = "cytotoxic peptides, dolastatin 10, multidrug resistance, P-glycoprotein, peptide transport, tubulin binding drug",
author = "Toppmeyer, {Deborah L.} and Slapak, {Christopher A.} and James Croop and Kufe, {Donald W.}",
year = "1994",
month = "8",
day = "3",
doi = "10.1016/0006-2952(94)90292-5",
language = "English (US)",
volume = "48",
pages = "609--612",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Role of P-glycoprotein in dolastatin 10 resistance

AU - Toppmeyer, Deborah L.

AU - Slapak, Christopher A.

AU - Croop, James

AU - Kufe, Donald W.

PY - 1994/8/3

Y1 - 1994/8/3

N2 - Dolastatin 10, a cytotoxic pentapeptide isolated from the mollusk Dolabella auricularia, exhibits potent antitumor activity. The present studies demonstrated that sublines of murine PC4 and human U-937 leukemia cells expressing a multidrug resistance (MDR) phenotype are cross-resistant to this agent. We also demonstrated that such resistance was reversed by verapamil. While these findings suggested the involvement of the P-glycoprotein (P-gp) in dolastatin 10 resistance, we performed similar studies in a CHO cell line transfected with the human mdr 1 cDNA. Expression of P-gp in the transfected cells was associated with resistance to dolastatin 10 by a verapamil-sensitive mechanism. The demonstration that photoaffinity labeling of P-gp was decreased in the presence of dolastatin 10 further supports the interaction of this cytotoxic peptide with P-gp. Taken together, these findings suggest that resistance to dolastatin 10 is conferred, at least in part, by P-gp and that this cytotoxic peptide is a novel member of the MDR phenotype.

AB - Dolastatin 10, a cytotoxic pentapeptide isolated from the mollusk Dolabella auricularia, exhibits potent antitumor activity. The present studies demonstrated that sublines of murine PC4 and human U-937 leukemia cells expressing a multidrug resistance (MDR) phenotype are cross-resistant to this agent. We also demonstrated that such resistance was reversed by verapamil. While these findings suggested the involvement of the P-glycoprotein (P-gp) in dolastatin 10 resistance, we performed similar studies in a CHO cell line transfected with the human mdr 1 cDNA. Expression of P-gp in the transfected cells was associated with resistance to dolastatin 10 by a verapamil-sensitive mechanism. The demonstration that photoaffinity labeling of P-gp was decreased in the presence of dolastatin 10 further supports the interaction of this cytotoxic peptide with P-gp. Taken together, these findings suggest that resistance to dolastatin 10 is conferred, at least in part, by P-gp and that this cytotoxic peptide is a novel member of the MDR phenotype.

KW - cytotoxic peptides

KW - dolastatin 10

KW - multidrug resistance

KW - P-glycoprotein

KW - peptide transport

KW - tubulin binding drug

UR - http://www.scopus.com/inward/record.url?scp=0028060035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028060035&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(94)90292-5

DO - 10.1016/0006-2952(94)90292-5

M3 - Article

C2 - 7915113

AN - SCOPUS:0028060035

VL - 48

SP - 609

EP - 612

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 3

ER -